SERVICES
Independent consulting in evidence generation and market access — engaged for a single deliverable or as an extension of your team.
SLRs and TLRs that underpin evidence generation plans and market access submissions — scoped to the decision they need to support.
Real-world evidence is now central to access decisions. I contribute to RWE initiatives at global, regional and national level, from shaping the evidence plan and study design to interpreting results for payer and HTA audiences.
HEOR support including economic modelling and the adaptation of global value dossiers to local markets and HTA requirements.
Advice on market access strategy and on engagement with Health Technology Assessment bodies and payers, so the evidence package answers the questions decision-makers will actually ask.
Bring your team up to speed fast, with HEOR fundamentals, market access executive education and bespoke programmes for pharma and consultancy teams. HEOR Fundamentals is a course on the methods and HTA systems that drive global pharma revenue; bespoke training is built around your team's specific gaps.
Describe the question and I'll suggest the shortest path to an answer.